CellChorus Analysis: $3M Raised
What is CellChorus?
CellChorus builds the TIMING platform for time-lapse microscopy of single cells in nanowell grids. The system uses visual AI to track activation, killing, movement, apoptosis, and cytokine secretion over time. The company was spun out of the Single Cell Lab at the University of Houston and serves biopharmaceutical teams studying immune-cell behavior and therapy response.
Location
Houston, TX 77004, US
Employees
11-50
Founded
2020
Revenue
$1.4M
Product Features & Capabilities
- TIMING™ platform, single-cell technology, evaluates cell movement, activation, interaction, killing, survival, time-lapse imaging microscopy, neural network detection, characterizes migration, contact dynamics, cell death, high-throughput microscopy experiments, artificial intelligence application, integrates motion and performance with multi-omic profiling, adaptable to various biology and cell types.
How much CellChorus raised
Grant - $2,500,000
May 2, 2024Lead Investor: NCATS
Who are the founders of CellChorus
DM
Dan Meyer
CEO
NV
Navin Varadarajan
Founder
Investors
- National Institutes of Health (NIH)
- National Center for Advancing Translational Sciences (NCATS)
- Y Combinator
- NVIDIA Inception
- National Institute of General Medical Sciences
- Asymmetry Ventures
- Texas Halo Fund
Market Focus
CellChorus primarily focuses on the biotechnology industry, specifically in the field of immunology and single-cell analysis technologies for clinical applications.
Competitors Overview
CellChorus operates in the single-cell technology market, specifically focusing on immune cell evaluation through its TIMING™ platform. Its main competitors include:
-
10x Genomics: Known for its Gel Bead-in-Emulsions (GEM) technology, 10x Genomics offers high-throughput single-cell analysis platforms. Their technology allows for comprehensive genomic profiling, which can be advantageous for researchers needing detailed genetic information from individual cells.
-
BD (Becton, Dickinson and Company): BD provides a range of single-cell analysis tools, including flow cytometry and cell sorting technologies. Their established presence in the market and extensive product range give them a competitive edge in clinical and research applications.
-
Illumina: While primarily known for sequencing technologies, Illumina also offers solutions for single-cell analysis. Their integration of sequencing with single-cell technologies allows for in-depth analysis of cellular heterogeneity.
-
Fluidigm Corporation (Standard BioTools Inc.): Fluidigm specializes in single-cell genomics and proteomics, offering platforms that enable high-throughput analysis of single cells. Their focus on both genomic and protein analysis provides a unique advantage in multi-omics studies.
-
QIAGEN: QIAGEN offers various solutions for single-cell analysis, including sample preparation and bioinformatics tools. Their comprehensive approach to sample handling and analysis can be beneficial for researchers looking for integrated solutions.
Notable differences include CellChorus's emphasis on dynamic analysis of immune cell interactions using visual AI, which may provide unique insights into cellular behavior compared to the more traditional genomic and proteomic approaches of its competitors.
See something that needs updating? Suggest edits to this profile.